also on other fortune lists

company facts

f500 stats

Fortune 500

Boston Globe via Getty Images




In Ian Read’s final year as the company’s CEO, Pfizer managed to grow revenues by just 2% as it adjusted to greater competition to—and diminished sales of—Viagra and other drugs on which the company lost patent exclusivity in 2017. The pharmaceutical giant is now in the midst of a reorganization since announcing in the summer of 2018 that it would separate its business into three parts, one of which (its consumer health division) it plans to merge into a joint venture with GlaxoSmithKline. The moves are designed to position Pfizer for greater sales growth under new CEO Albert Bourla.

Looking for leads, investment insights, or competitive intelligence?


Albert Bourla

CEO Title

Chief Executive Officer & Director


Health Care



HQ Location

New York, N.Y.

Years on Fortune 500 List




Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$53,6472.1%
Profits ($M)$11,153.0-47.7%
Assets ($M)$159,422
Total Stockholder Equity ($M)$63,407
Profit Ratios
Profit as % of Revenues20.8%
Profits as % of Assets7.0%
Profits as % of Stockholder Equity17.6%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)1.87
EPS % Change (from 2017)-46.9%
EPS % Change (5 year annual rate)-10.1%
EPS % Change (10 year annual rate)4.5%
Total Return
Total Return to Investors (2018)24.7%
Total Return to Investors (5 year, annualized)11.2%
Total Return to Investors (10 year, annualized)13.8%
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Pfizer

Facebook Reveals Its Cryptocurrency Play: CEO Daily

Must-read business news, delivered every morning.

Read More →
Pfizer Betting Big on Cancer Research in $11.4 Billion Acquisition of Array BioPharma

Pfizer expects the transaction to add to earnings per share starting in 2022.

Read More →
Why A.I. Just Might Save Your Job

Walmart’s new robot “smart assistants” are good news for employees.

Read More →
Data Sheet–Drug Discovery Shifting From Treatment to Cure

This is your Data Sheet newsletter for Thursday, April 4, 2019.

Read More →